Delivery Order SPE2DE22D0008-SPE2D626F7E52
Award Date 3/30/26
Potential Completion Date 4/2/26
Potential Value $1.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency's Medical Supply Chain issued a $6,943 delivery order to Alba Bioscience, Inc. on March 2, 2026, for ALBACLONE Anti-S monoclonal antibodies, with an ultimate completion date of March 5, 2026.</p> <p>Place of performance is Chicago, IL. Alba Bioscience specializes in immunohematology reagents and blood banking diagnostic materials for federal healthcare systems. The order is priced on a firm fixed price basis with no set-aside designation.</p>
- The Defense Logistics Agency's Medical Supply Chain issued a $1,156.60 delivery order to Alba Bioscience, Inc. on March 24, 2026, for ALBACLONE Anti-LEA monoclonal antibodies, with ultimate completion on March 27, 2026. Place of performance is Chicago, IL 60607. Alba Bioscience specializes in immunohematology reagents and blood banking diagnostic products for federal healthcare systems, including monoclonal antibodies targeting various blood group antigens, antibody identification and...
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,750 delivery order to Alba Bioscience, Inc. on March 12, 2026, for ALBACLONE Anti-C monoclonal antibody reagent, with completion by March 17, 2026. Place of performance is Chicago, IL. Alba Bioscience supplies immunohematology reagents and blood banking diagnostic materials to federal healthcare systems, including monoclonal antibodies, antibody identification and screening panels, quality control kits, and specialized cell...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,194.00 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-D Blend, a monoclonal antibody reagent used in blood banking and immunohematology testing. The contract is structured as a firm fixed-price delivery order with a completion date of January 30, 2026, and was awarded on January 27, 2026. This award carries no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,123.00 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-D Blend, a monoclonal antibody product used in immunohematology and blood banking operations. The contract is firm fixed-price with no set-aside designation and an ultimate completion date of December 22, 2025. Alba Bioscience, a Chicago-based for-profit subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,080 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-E monoclonal antibodies under a firm fixed price contract. The award, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, represents a competitive procurement with no set-aside designation. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,370.00 to Alba Bioscience, Inc. for ALBACLONE Anti-A antibodies, with performance completion targeted for August 19, 2025. This non-set-aside contract represents a firm fixed price delivery order for specialized blood banking diagnostic reagents to be delivered to Chicago, Illinois. Alba Bioscience, a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., has established itself as a critical...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,422.00 delivery order contract to Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics specializing in in vitro diagnostic products and blood banking materials. The award, issued on December 12, 2025, with an ultimate completion date of December 17, 2025, is for ALBACLONE Anti-A monoclonal antibodies used in blood typing and immunohematology testing. This firm fixed-price delivery order carries no...
- Alba Bioscience, Inc. was awarded a delivery order valued at $1,123.00 by the Medical Supply Chain division of the Defense Department on July 29, 2025, with an ultimate completion date of August 1, 2025. The contract, identified as 4568920078, covers the supply of ALBACLONE Anti-A antibodies, specialized reagents used in blood banking and immunohematology testing. This non-set-aside award was issued under a firm fixed-price arrangement, with performance to be completed in Chicago, Illinois. Alba...
- Alba Bioscience, Inc. was awarded a delivery order contract on July 15, 2025, for ALBACLONE Anti-K antibodies with a firm fixed price ceiling value of $3,400. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed in Chicago, Illinois, with an ultimate completion date of July 18, 2025. This non-set-aside award recognizes Alba Bioscience's established position as a critical supplier of in vitro diagnostic reagents and blood bank products to...